Evidence mapPaperPMID 41259090Full record

ArticleJMIR pediatrics and parenting2025

Monetary Valuation of Congenital Heart Disease in Indonesia: Economic Modeling Study.

Muhammad Iqhrammullah, Derren Dch Rampengan, Ikhwan Amri, Surna Lastri, Starry H Rampengan, Radityo Prakoso, Muhammad Habiburrahman

Abstract read
In one paragraph

Article in JMIR pediatrics and parenting, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Muhammad IqhrammullahPostgraduate Program of Public Health, Universitas Muhammadiyah Aceh, Banda Aceh, Indonesia.ORCID https://orcid.org/0000-0001-8060-7088
Derren Dch RampenganFaculty of Medicine, Sam Ratulangi University, Manado, Indonesia.ORCID https://orcid.org/0009-0002-5482-0613
Ikhwan AmriDepartment of Geography Education, Faculty of Teacher Training and Education, Samudra University, Langsa, Indonesia.ORCID https://orcid.org/0000-0003-1440-7197
Surna LastriPostgraduate Program of Management, Universitas Muhammadiyah Aceh, Banda Aceh, Indonesia.ORCID https://orcid.org/0000-0001-9602-9446
Starry H RampenganDivision of Interventional Cardiology, Department of Cardiology and Vascular Medicine, R.D. Kandou Central General Hospital, Faculty of Medicine, Sam Ratulangi University, Manado, Indonesia.ORCID https://orcid.org/0009-0004-3335-0602
Radityo PrakosoDivision of Paediatric Cardiology and Congenital Heart Disease, Department of Cardiology and Vascular Medicine, National Cardiovascular Centre Harapan Kita, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.ORCID https://orcid.org/0000-0003-3345-6314
Muhammad HabiburrahmanFaculty of Medicine, Imperial College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-6372-8240

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCongenital heart disease (CHD) constitutes a significant health and economic burden in low- and middle-income countries, including Indonesia. However, its macroeconomic impact across provinces remains poorly quantified.

objectiveThis study aims to estimate the economic burden associated with premature death and disability due to CHD in Indonesia, with a focus on regional and gender disparities.

methodsUsing data from the Global Burden of Disease 2019 study, we assessed the value of lost welfare (VLW) attributable to CHD across all 34 Indonesian provinces. Economic valuation was conducted using 3 approaches: the US Department of Transportation model, a method based on the Organisation for Economic Co-operation and Development, and a national wage-based estimate. Analyses were stratified by sex and derived from both disability-adjusted life years (DALYs) and years of life lost. We examined disparities using two approaches: (1) gender disparity was measured as the relative difference in VLW between males and females, and (2) geographical disparity was quantified using both location quotients (for raw VLW) and a disparity index (for VLW-to-gross domestic product ratios).

resultsThe national CHD-related VLW derived from DALYs was estimated at US $16.83 billion (US Department of Transportation), US $11.41 billion (Organisation for Economic Co-operation and Development), and US $9.03 billion (wage-based). West Java recorded the highest provincial VLW (US $1.60 billion), followed by East Java (US $0.83 billion), North Sumatra (US $0.80 billion), and Central Java (US $0.79 billion), indicating a concentration of burden in populous provinces. In contrast, Yogyakarta (US $0.04 billion), North Kalimantan (US $0.04 billion), and West Papua (US $0.06 billion) had the lowest estimates. In several provinces, male-attributed VLW was more than 150% higher than female VLW, with extreme gaps observed in Riau Islands (281.25%), Aceh (166.10%), and Banten (145.86%). These patterns were consistent across both DALY- and years-of-life-lost-based estimates. Based on the location quotients, provinces such as Papua (2.42), West Sulawesi (2.37), Maluku (1.78), East Nusa Tenggara (1.75), and Central Sulawesi (1.66) bore VLW burdens far greater than their population share. The burden was disproportionately high in several eastern provinces, including East Nusa Tenggara (3.35%), Maluku (2.61%), and West Sulawesi (2.66%).

conclusionsCHD is a macroeconomically manageable burden across most of Indonesia. However, the presence of deep gender disparities and geographically concentrated burdens in eastern and underserved provinces calls for targeted pediatric cardiac health investments.

Indexed as

burden of diseaseeconomic burdenhealth economicshealth equitypediatric cardiology

Identifiers

PMID41259090
PMCPMC12676220

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.